Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Common Stock Options Outstanding and Related Activity

The following is a summary of stock option information and weighted average exercise prices:

	2023			2022
	Number of Options	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
Outstanding at January 1	598,155	$	24.35	739,762	$	26.15
Granted(1)	136,326	4.21		5,707	25.62
Exercised	(18,054)	3.12		(58,337)	4.42
Canceled(1)	(253,010)	30.26		(79,732)	52.46
Expired	(249)	4.06		(9,245)	60.76
Outstanding at December 31	463,168	16.03		598,155	24.35
Exercisable at December 31	440,324	$	15.19	524,974	$	20.34

(1) Includes 136,326 stock options repriced in September 2023, accounted for as a modification. Stock-based compensation related to the incremental fair value of repriced options was immaterial.

Schedule of Key Weighted Average Assumptions

The key assumptions for grants presented on a weighted average basis are as follows:

	Year Ended December 31,
	2023		2022
Expected volatility	47.6	%	68.2	%
Risk-free rate	4.2	%	2.0	%
Expected term in years	4.7		6.1
Dividend yield	—	%	—	%

Summary of Nonvested Restricted Stock Units

The following is a summary of RSU information and weighted average grant date fair values for the Company's RSUs:

	Year Ended December 31,
	2023			2022
	Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value
Unvested at January 1	494,671	$	37.77	290,220	$	57.15
Granted	1,331,899	3.96		545,692	34.33
Vested	(286,601)	35.17		(94,552)	54.51
Forfeited	(75,896)	35.57		(246,689)	46.55
Unvested at December 31	1,464,073	$	7.64	494,671	$	37.77

Schedule of Nonvested Performance Restricted Stock Units

The following is a summary of PRSU information and weighted average grant date fair values for the Company's PRSUs:

	Year Ended December 31,
	2023			2022
	Shares	Weighted Average Grant Date Fair Value		Shares	Weighted Average Grant Date Fair Value
Unvested at January 1	87,321	$	36.36	—	$	—
Granted	—	—		132,433	36.37
Vested	(7,518)	36.40		—	—
Forfeited	(8,375)	35.97		(45,112)	36.40
Unvested at December 31	71,428	$	36.40	87,321	$	36.36

Schedule of Stock-based Compensation Expense

Total stock-based compensation was recognized as follows (in thousands):

	Year Ended December 31,
	2023		2022
General and administrative	$	5,391	$	7,117
Sales and marketing	1,720		2,216
Research and development	2,822		3,523
Total stock-based compensation	$	9,933	$	12,856